fingolimod hydrochloride has been researched along with HIV Coinfection in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Darazam, IA; Gharehbagh, FJ; Hatami, F; Lotfollahi, L; Moradi, O; Nourinia, R; Rabiei, MM; Roozbeh, M; Shojaei, M | 1 |
| Betts, MR; Cervasi, B; Chomont, N; Deleage, C; Ehnert, S; Freeman, ML; Gill, KP; Harper, JL; Jean, SM; King, CT; Kulpa, D; Lederman, MM; Lifson, JD; Nguyen, K; Pagliuzza, A; Paiardini, M; Pampena, MB; Pino, M; Samer, S; Shim, I; Viox, EG; Zhang, A | 1 |
| Bosque, A; Bukrinsky, M; Chomont, N; Dubrovsky, L; Fromentin, R; Newman, D; Resop, RS; Rigsby, H | 1 |
| Aubert, RD; Butler, K; Garber, D; Henning, T; Jenkins, L; Kersh, EN; McNicholl, J; Mitchell, J; Morris, M | 1 |
| Adams, D; Bachman, S; Dinh, C; Hendry, M; Henning, T; Kersh, E; Luo, W; McNicholl, J; Mitchell, J; Powell, N; Sharma, P; Sweeney, E; Tsuiki, A; Vishwanathan, S | 1 |
6 other study(ies) available for fingolimod hydrochloride and HIV Coinfection
| Article | Year |
|---|---|
A Case of Fingolimod-associated Cryptococcal Meningitis.
Topics: Adult; Antifungal Agents; Cryptococcus neoformans; Female; Fingolimod Hydrochloride; HIV Infections; Humans; Meningitis, Cryptococcal | 2022 |
Limited impact of fingolimod treatment during the initial weeks of ART in SIV-infected rhesus macaques.
Topics: Animals; Anti-Retroviral Agents; CD4-Positive T-Lymphocytes; Fingolimod Hydrochloride; HIV Infections; Macaca mulatta; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Viral Load | 2022 |
Fingolimod inhibits multiple stages of the HIV-1 life cycle.
Topics: Fingolimod Hydrochloride; HIV Infections; HIV-1; Humans; Lysophospholipids; Phosphorylation; SAM Domain and HD Domain-Containing Protein 1; Signal Transduction; Sphingosine; Sphingosine 1 Phosphate Receptor Modulators; T-Lymphocytes; Virus Latency; Virus Replication | 2020 |
Preclinical evaluation of the immunomodulatory lymphocyte trafficking drug FTY720 for HIV prevention in the female genital mucosa of macaques.
Topics: Administration, Intravaginal; Administration, Intravenous; Animals; Cervix Uteri; Drug Evaluation, Preclinical; Female; Fingolimod Hydrochloride; HIV Infections; Immunomodulation; Immunosuppressive Agents; Lymphocytes; Macaca nemestrina; Mucous Membrane; Pilot Projects; Propylene Glycols; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Sphingosine; Vagina | 2014 |
News & views in ... Immunotherapy.
Topics: Animals; Antibodies, Blocking; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Female; Fingolimod Hydrochloride; HIV Envelope Protein gp120; HIV Infections; Humans; Maximum Tolerated Dose; Multiple Sclerosis; Ovarian Neoplasms; Propylene Glycols; Sphingosine; Thymidylate Synthase; Virus Internalization | 2009 |
Evaluation of the lymphocyte trafficking drug FTY720 in vaginal tissues.
Topics: Administration, Intravaginal; Administration, Intravenous; Animals; Anti-Infective Agents; Cervix Uteri; Drug Evaluation, Preclinical; Female; Fingolimod Hydrochloride; HIV Infections; Immunosuppressive Agents; Interleukin 1 Receptor Antagonist Protein; Interleukin-8; Lymphocyte Count; Macaca nemestrina; Mucous Membrane; Pilot Projects; Placebos; Propylene Glycols; Sphingosine; Vagina; Vaginal Creams, Foams, and Jellies | 2013 |